Colgate-Palmolive (CL) Beats Q1 2026 on Revenue and EPS as Shares Gain
Colgate-Palmolive topped Q1 2026 estimates with EPS of $0.97 and revenue of $5.32B, up 8.4% YoY. Shares rose 1.03% to $85.36.
Colgate-Palmolive Company (NYSE: CL) is a consumer sector company, listed on the NYSE. Alpha Stocks Insight tracks CL across all major catalysts: quarterly earnings reports, analyst upgrades and downgrades, mergers and acquisitions, regulatory decisions, and significant price moves driven by sector or macro developments. This page centralises 2 articles published since May 1, 2026, providing investors with timely, data-driven analysis of Colgate-Palmolive Company's financial performance and competitive position. New coverage is added each trading day.
Colgate stock rises despite flat EPS growth, as emerging market strength and 8.4% revenue growth balance elevated cost inflation.
Colgate-Palmolive topped Q1 2026 estimates with EPS of $0.97 and revenue of $5.32B, up 8.4% YoY. Shares rose 1.03% to $85.36.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.